Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

BACKGROUND. The Maintenance in Colorectal Cancer trial was a phase III study to assess maintenance therapy with single-agent bevacizumab versus bevacizumab plus chemotherapy in patients with metastatic colorectal cancer. An ancillary study was conducted to evaluate the circulating tumor cell (CTC) c...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Sastre, Javier, Maestro, M. Luisa, Gómez-España, Auxiliadora, Rivera, Fernando, Valladares, Manuel, Massuti, Bartomeu, Benavides, Manuel, Gallén, Manuel, Marcuello, Eugenio, Abad, Albert, Arrivi, Antonio, Fernández-Martos, Carlos, González, Encarnación, Tabernero, Josep M., Vidaurreta, Marta, Aranda, Enrique, Díaz-Rubio, Eduardo
格式: Artigo
語言:Inglês
出版: AlphaMed Press 2012
主題:
Gastrointestinal Cancer
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399651/
https://ncbi.nlm.nih.gov/pubmed/22643538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0048
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍